Oxford Medical Products
Generated by Meeveem AI
"Pioneering gastroretentive hydrogel technology for weight management and drug delivery"
Witney
•11 - 50 Employees
•Medical Devices
About Oxford Medical Products
Oxford Medical Products develops a proprietary gastroretentive hydrogel platform that enables new approaches to treating obesity and delivering medicines. The technology underpins two core assets: Sirona, a non pharmacological treatment for managing overweight and obesity, and OMP GEL, a drug delivery platform for controlled release of small molecules and biologics. The company partners with drug developers to deliver their active pharmaceutical ingredients using this hydrogel based long term gastroretentive system. The platform enhances oral bioavailability, improves pharmacokinetic profiles, and can reduce dosing frequency, transforming once daily pills into once weekly treatments.
21
Team Members
2016
Founded
Medical Devices
Sector
On-Site
Work Environment
Our Vision
A world where accessible, non invasive biomaterial solutions make weight management and medication delivery simpler, safer and more effective for everyone.
Our Mission
Enables innovative approaches to weight management and oral drug delivery through proprietary gastroretentive hydrogel platform technology.